These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 15795549)

  • 21. An overview of the efficacy and tolerability of new antiepileptic drugs.
    Chadwick DW
    Epilepsia; 1997; 38 Suppl 1():S59-62. PubMed ID: 9092963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of partial seizures in childhood : an overview.
    Coppola G
    CNS Drugs; 2004; 18(3):133-56. PubMed ID: 14871158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pregabalin or placebo used adjunctively with levetiracetam in refractory partial-onset epilepsy: a post hoc efficacy and safety analysis in combined clinical trials.
    Uthman BM; Almas M; Emir B; Giordano S; Leon T
    Curr Med Res Opin; 2011 Jul; 27(7):1285-93. PubMed ID: 21561392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of levetiracetam on the pharmacokinetics of adjunctive antiepileptic drugs: a pooled analysis of data from randomized clinical trials.
    Gidal BE; Baltès E; Otoul C; Perucca E
    Epilepsy Res; 2005; 64(1-2):1-11. PubMed ID: 15823510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative efficacy and tolerability of anti-epileptic drugs for refractory focal epilepsy: systematic review and network meta-analysis reveals the need for long term comparator trials.
    Bodalia PN; Grosso AM; Sofat R; Macallister RJ; Smeeth L; Dhillon S; Casas JP; Wonderling D; Hingorani AD
    Br J Clin Pharmacol; 2013 Nov; 76(5):649-67. PubMed ID: 23351090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Newer antiepileptic drugs. Towards an improved risk-benefit ratio.
    Patsalos PN; Sander JW
    Drug Saf; 1994 Jul; 11(1):37-67. PubMed ID: 7917080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiepileptic Drug Treatment in Community-Dwelling Older Patients with Epilepsy: A Retrospective Observational Study of Old- Versus New-Generation Antiepileptic Drugs.
    Theitler J; Brik A; Shaniv D; Berkovitch M; Gandelman-Marton R
    Drugs Aging; 2017 Jun; 34(6):479-487. PubMed ID: 28478592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The new antiepileptic drugs: a systematic review of their efficacy and tolerability.
    Marson AG; Kadir ZA; Hutton JL; Chadwick DW
    Epilepsia; 1997 Aug; 38(8):859-80. PubMed ID: 9579887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures.
    Piña-Garza JE; Nordli DR; Rating D; Yang H; Schiemann-Delgado J; Duncan B;
    Epilepsia; 2009 May; 50(5):1141-9. PubMed ID: 19243423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Second-generation antiepileptic drugs' impact on balance: a meta-analysis.
    Sirven JI; Fife TD; Wingerchuk DM; Drazkowski JF
    Mayo Clin Proc; 2007 Jan; 82(1):40-7. PubMed ID: 17285784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Some common issues in the use of antiepileptic drugs.
    Asconapé JJ
    Semin Neurol; 2002 Mar; 22(1):27-39. PubMed ID: 12170391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aggravation of partial seizures by antiepileptic drugs: is there evidence from clinical trials?
    Somerville ER
    Neurology; 2002 Jul; 59(1):79-83. PubMed ID: 12105311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical efficacy and safety of the newer antiepileptic drugs as adjunctive treatment in adults with refractory partial-onset epilepsy: a meta-analysis of randomized placebo-controlled trials.
    Gao L; Xia L; Zhao FL; Li SC
    Epilepsy Res; 2013 Jan; 103(1):31-44. PubMed ID: 22776828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retigabine for the adjunctive treatment of adults with partial-onset seizures in epilepsy with and without secondary generalization : a NICE single technology appraisal.
    Craig D; Rice S; Paton F; Fox D; Woolacott N
    Pharmacoeconomics; 2013 Feb; 31(2):101-10. PubMed ID: 23341194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of antiepileptic drugs for refractory partial-onset epilepsy: a network meta-analysis.
    Hu Q; Zhang F; Teng W; Hao F; Zhang J; Yin M; Wang N
    J Neurol; 2018 Jan; 265(1):1-11. PubMed ID: 28940083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group.
    Ben-Menachem E; Falter U
    Epilepsia; 2000 Oct; 41(10):1276-83. PubMed ID: 11051122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The efficacy and safety of retigabine and other adjunctive treatments for refractory partial epilepsy: a systematic review and indirect comparison.
    Martyn-St James M; Glanville J; McCool R; Duffy S; Cooper J; Hugel P; Lane PW
    Seizure; 2012 Nov; 21(9):665-78. PubMed ID: 22902288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and Tolerability of Second and Third Generation Anti-epileptic Drugs in Refractory Epilepsy: A Network Meta-Analysis.
    Zhuo C; Jiang R; Li G; Shao M; Chen C; Chen G; Tian H; Li J; Xue R; Jiang D
    Sci Rep; 2017 May; 7(1):2535. PubMed ID: 28566726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed?
    Johannessen SI; Tomson T
    Clin Pharmacokinet; 2006; 45(11):1061-75. PubMed ID: 17048972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of levetiracetam in partial seizures.
    Devinsky O; Elger C
    Epileptic Disord; 2003 May; 5 Suppl 1():S27-31. PubMed ID: 12915338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.